Position in TNGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$44,332,711
+$42,924,252 QoQ
Shares Held
1,418,193
+2006.5% QoQ
Ownership
0.841%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 247 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. TNGX ranks #34 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in TNGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,332,711 | 1,418,193 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $1,408,459 | 67,326 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $503,557 | 56,835 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $284,893 | 33,916 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $341,375 | 66,675 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $42,792 | 31,236 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $96,756 | 31,313 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $406,867 | 52,840 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $442,374 | 51,559 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $974,212 | 122,697 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $493,049 | 49,803 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $532,057 | 47,252 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $131,564 | 39,628 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $240,827 | 60,969 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $362,419 | 49,989 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $151,514 | 41,855 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $223,451 | 49,327 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $198,875 | 26,237 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $355,932 | 32,535 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,429 | 1,812 | Shares | Defined | 2021-11-12 | |
| 2020-09-30 BCTG | — | 100,000 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||